Choriocarcinoma: Clinical Trials

5 trials for Choriocarcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 terminated. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Recruiting 2, Terminated 1

Follow Choriocarcinoma: new trials by email Literature Review of Choriocarcinoma trials Research Report on Choriocarcinoma

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors
High-dose chemotherapy (TI- 2 cycles, CE- 3 cycles ) - Germ Cell Tumor
Phase 2RecruitingN.N. Petrov National Medical Research Center of Oncology252024-03-012025-08-03
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
Biospecimen Collection, Carboplatin, Etoposide - Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma
Phase 2RecruitingChildren's Oncology Group1602021-07-132026-09-23
Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)
TRC105, Bevacizumab - Gestational Trophoblastic Neoplasia, Choriocarcinoma
Phase 2TerminatedTracon Pharmaceuticals Inc.32016-03-012019-07-23
TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma
TRC105, Bevacizumab - Choriocarcinoma
Phase 2CompletedTracon Pharmaceuticals Inc.22015-01-012019-06-11
A Trial for Patients With Gestational Trophoblastic Disease
Pemetrexed - Trophoblastic Neoplasms, Uterine Neoplasms
Phase 2CompletedEli Lilly and Company502006-07-012007-08-09

Narrower conditions

Teratoma (2)  ·  Carcinoma, Embryonal (1)  ·  Endodermal Sinus Tumor (1)  ·  Germinoma (1)  ·  Gestational Trophoblastic Disease (1)  ·  Hydatidiform Mole (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Nonseminomatous germ cell tumor (1)  ·  Seminoma (1)  ·  Trophoblastic Neoplasms (1)  ·  Trophoblastic Tumor, Placental Site (1)  ·  Uterine Neoplasms (1)

Broader conditions

Adenocarcinoma (5)  ·  Carcinoma (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplasms, Glandular and Epithelial (5)  ·  Pregnancy Complications (5)  ·  Pregnancy Complications, Neoplastic (5)  ·  Urogenital Diseases (5)  ·  Neoplasms, Germ Cell and Embryonal (4)  ·  Trophoblastic Neoplasms (4)  ·  Female Urogenital Diseases (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)

Interventions

Bevacizumab (2)  ·  carotuximab (2)  ·  Carboplatin (1)  ·  Drug Therapy (1)  ·  Etoposide (1)  ·  Filgrastim (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Ifosfamide (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Mesna (1)  ·  Pemetrexed (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  Radiation (1)  ·  Radiotherapy (1)  ·  Reoperation (1)

Sponsors

Tracon Pharmaceuticals Inc. (2)  ·  Children's Oncology Group (1)  ·  Eli Lilly and Company (1)  ·  N.N. Petrov National Medical Research Center of Oncology (1)

Countries

United States (4)  ·  Australia (1)  ·  Canada (1)  ·  New Zealand (1)  ·  Russia (1)

Top investigators

Aleksei M Belyaev, MD,DSc,Prof. (1)  ·  Charles Theuer, MD (1)  ·  Charles Theuer, MD, PhD (1)  ·  David Miller, MD (1)  ·  Shannon M MacDonald (1)  ·  Tatyana Yu Semiglazova, MD,DSc,Prof. (1)

NIH funding

U10CA180886 (1)